Patricia A Barditch-Croovo

Johns Hopkins University

$346,501

Attributed

$346,501

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $164K · FY2005–06

$200K$150K$100K$50K$0

'05

'06

Funding mix

By agency

NIH$346,501 · 5

By mechanism

M01$346,501 · 5

Top collaborators

No co-investigators on record.

Most similar at Johns Hopkins University

Same institution · by research overlap

Charles W. Flexner$41,000,447
John G Bartlett$1,448,360
Steven D Gore$7,773,366
Richard E Chaisson$50,014,616
Namandje N Bumpus$8,550,966

Others in their field

Top investigators on “Patient Oriented Research”

Praduman Jain · Vignet, Inc.$103,566,231
Larry Arthur$103,000,000
Charles A Coltman · Southwest Oncology Group$87,961,334
Gregory H Reaman · National Childhood Cancer Foundation$61,988,461
Steven E Reis · University Of Pittsburgh At Pittsburgh$61,626,874
Steven M. Dubinett · Va Greater Los Angeles Healthcare System$57,862,577

Research focus

Patient Oriented ResearchHuman SubjectHuman Therapy EvaluationClinical ResearchAids TherapyReverse Transcriptase InhibitorsAntiaids AgentRitonavirPharmacokineticsDrug Screening /EvaluationMicroorganism Disease ChemotherapyCombination ChemotherapyProtease InhibitorIndinavirRibavirinStavudineZidovudineAmlodipineAntihypertensive AgentsAntiviral AgentsCalcium Channel BlockersClinical Trial Phase IClinical Trial Phase IiComorbidity

Grant awards (5)

ATAZANAVIR AND LOPINAVIR/RITONAVIR WHEN CO-ADMINISTERED TO HIV-SERONEGATIVE$163,996

M01 · FY2006 · RR · contact PI

ATAZANAVIR AND LOPINAVIR/RITONAVIR WHEN CO-ADMINISTERED TO HIV-SERONEGATIVE$162,365